Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 65,217 | 71,434 | 60,698 | 47,485 | 49,581 |
| Operating Income | -65,217 | -71,434 | -60,698 | -47,485 | -49,581 |
| Interest Expense | 1,995 | 3,198 | 2,037 | 18 | 0 |
| Other Income | 4,443 | 4,053 | 6,779 | 7,097 | 3,226 |
| Pre-tax Income | -62,769 | -70,579 | -55,956 | -40,406 | -46,355 |
| Income Tax | 248 | 115 | 95 | 153 | 41 |
| Net Income Continuous | -63,017 | -70,694 | -56,051 | -40,559 | -46,396 |
| Minority Interests | -592 | -965 | -831 | -615 | -790 |
| Net Income | $-62,425 | $-69,729 | $-55,220 | $-39,944 | $-45,606 |
| EPS Basic Total Ops | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 |
| EPS Basic Continuous Ops | -0.93 | -1.12 | -0.89 | -0.64 | -0.74 |
| EPS Diluted Total Ops | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 |
| EPS Diluted Continuous Ops | -0.93 | -1.12 | -0.89 | -0.64 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -1.10 | -0.87 | -0.63 | -0.72 |
| EBITDA(a) | $-64,466 | $-70,689 | $-59,956 | $-47,107 | $-49,217 |